GenSpera To Present At ICV Manhattan Investor Conference

SAN ANTONIO--(BUSINESS WIRE)--GenSpera, Inc. (OTC/QB: GNSZ), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announces that President and CEO Craig A. Dionne, Ph.D., will present a corporate overview at ICV Manhattan Investor Conference today, Tuesday, December 8, 2015, at 10:15 a.m. Eastern time. The conference is being held at the Mandarin Oriental Hotel in New York City.